It’s been just over six months since NHS England made cladribine (Mavenclad) available to patients with highly-active relapsing remitting multiple sclerosis (RRMS) in England, but according to a...
Our news web pages include ground-breaking multiple sclerosis news and research from around the world.
These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.
Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.
We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years.
It’s been just over six months since NHS England made cladribine (Mavenclad) available to patients with highly-active relapsing remitting multiple sclerosis (RRMS) in England, but according to a...
A new study, published in the journal Neurology, has linked psychiatric conditions, such as depression, anxiety...
Results from the CHANGE-MS phase 2b study of GNbAC1 have shown that GNbAC1 administration has a significant, consistent positive...
A recent study of siponimod has highlighted the drug as the first potential therapy to meaningfully delay disability progression in secondary progressive MS (SPMS) patients.
Full results...
In the last decade mesenchymal stem cells (MSC) have been used to safely treat certain immune and inflammatory conditions such as multiple sclerosis (MS).
Scientists have recently completed...
Google has introduced 'wheelchair accessible' routes in transport navigation to make getting around city centres easier for those with mobility needs.
...
While examining human brain tissues, researchers from the University of Alberta and McGill University found that the tissues from people who had multiple sclerosis (MS) contained an extremely high...
The University of Warwick is leading a project to help unemployed people with long-term pain conditions back into work.
...
A study has found that multiple sclerosis (MS) patients with migraine, hyperlipidaemia or more than three comorbidities have an increased risk of relapse.
Comorbid conditions, such as...
Children and adults who spend more time outside are less likely to develop multiple sclerosis (MS) in later life, a US study has suggested.
Although previous studies have highlighted how UV...